Relation of brachial and digital measures of vascular function in the community: the Framingham heart study.
Impaired vascular function contributes to the development of clinical cardiovascular disease. The relation between vasodilator function assessed noninvasively in the brachial and digital arteries remains incompletely defined. In the Framingham Offspring, Third Generation and Omni Cohorts, we measured flow-mediated dilation (FMD; n = 7031; age 48 ± 13 years; age range, 19 to 88 years; 54% women) and peripheral arterial tonometry (PAT) ratio (n = 4352; 55 ± 16 years; age range, 19 to 90 years; 51% women). Abnormal vascular function for each measure was defined by the sex-specific fifth percentile in a reference group free of conventional cardiovascular risk factors. The prevalence of abnormal FMD but not abnormal PAT ratio was higher with advancing age. In multivariable models, higher body mass index was associated with a higher prevalence of both abnormal FMD and PAT ratio. Additional correlates of abnormal FMD included increasing age and higher systolic blood pressure. In contrast, correlates of abnormal PAT ratio included lower systolic blood pressure, increasing total/high-density lipoprotein cholesterol ratio, diabetes, smoking, and lipid-lowering medication. Whereas women had higher FMD and PAT ratios compared with men, using sex-specific reference values, women had a higher prevalence of abnormal brachial and digital vascular function. In participants who had concurrent testing (n = 1843), PAT ratio was not significantly associated with FMD in multivariable models. In this large, community-based cohort, brachial and digital measures of vascular function had differing relations with cardiovascular risk factors and were nearly uncorrelated with each other. These results suggest that FMD and PAT provide distinct information regarding vascular function in conduit versus smaller digital vessels.
Whitaker Cardiovascular Institute, School of Medicine, Boston University, Boston, MA 02118, USA. naomi.hamburg@bmc.org
Naomi M
NM
Hamburg
Joseph
J
Palmisano
Martin G
MG
Larson
Lisa M
LM
Sullivan
Birgitta T
BT
Lehman
Ramachandran S
RS
Vasan
Daniel
D
Levy
Gary F
GF
Mitchell
Joseph A
JA
Vita
Emelia J
EJ
Benjamin
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001783:Blood Flow Velocity / Q000502:physiology*; D001916:Brachial Artery / Q000000981:diagnostic imaging* / Q000502:physiology; D004730:Endothelium, Vascular / Q000000981:diagnostic imaging* / Q000502:physiology; D005260:Female; D006801:Humans; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D012039:Regional Blood Flow / Q000502:physiology; D014463:Ultrasonography; D014664:Vasodilation / Q000502:physiology*
Am J Epidemiol. 1979 Sep;110(3):281-90
474565
Methods Enzymol. 2005;396:541-53
16291261
Am J Cardiol. 2008 Jan 1;101(1):89-94
18157971
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2113-9
17717291
J Am Coll Cardiol. 2003 Oct 1;42(7):1149-60
14522472
Circulation. 2004 Feb 10;109(5):613-9
14769683
Circulation. 2005 Dec 13;112(24):3722-8
16330686
Circulation. 2009 Aug 11;120(6):502-9
19635967
Trends Cardiovasc Med. 2009 Jan;19(1):6-11
19467447
Circulation. 2003 Oct 28;108(17):2049-53
14581383
Am J Epidemiol. 2007 Jun 1;165(11):1328-35
17372189
Hypertension. 2004 Aug;44(2):134-9
15249547
J Appl Physiol (1985). 2006 Aug;101(2):545-8
16614356
Cardiovasc Res. 2005 May 1;66(2):286-94
15820197
Circulation. 2004 Nov 2;110(18):2918-23
15505080
Am J Physiol. 1996 Apr;270(4 Pt 2):H1435-40
8967386
Am J Physiol. 1994 Dec;267(6 Pt 2):H2087-90
7810709
Circulation. 1994 Nov;90(5):2556-9
7955218
Hypertension. 1996 Apr;27(4):849-53
8613259
Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2368-75
16141402
J Appl Physiol (1985). 2008 Aug;105(2):427-32
18483158
Eur Heart J. 2010 May;31(9):1142-8
20181680
Circulation. 2008 May 13;117(19):2467-74
18458169
Circulation. 2007 May 22;115(20):2628-36
17485578
Am Heart J. 2003 Jul;146(1):168-74
12851627
J Am Coll Cardiol. 1994 Aug;24(2):471-6
8034885
Circulation. 2007 May 8;115(18):2390-7
17452608